CAR-Immunotherapy TRIALS

CAR-Immunotherapy package has 22 parameters for all trials registered internationally through 30 June 2019, including their current status. Cumulatively, 763 CAR-Immunotherapy trials have been registered worldwide, including 118 in 2016, 152 in 2017, 234 in 2018, and 107 in the first half of 2019.

  • Trial Data
    • Registration Year
    • Trial ID with link to trial on-line
    • Country
    • Phase
    • Status (updated as of June 2019)
  • Patient Data
    • Indication
    • Patient Age Groups
    • Target Enrollment
  • Cell Data
    • CAR Target
    • Cell Type
    • Cell Source
    • Donor Type
    • CAR Construct (costimulatory domain, vector, etc)
    • Cell Dose(s)
    • Mode of Administration (route and # doses)
    • Conditioning
    • Drug Support/Combos
  • Sponsor Data
    • Academia or Industry Funding
    • Sponsor Name
    • Study Acronym
  • Additional Information
    • Product Name
    • Notes - includes secondary trial IDs and reasons for termination

A graph of CAR-Immunotherapy trial numbers and phase versus time shows the explosion of CAR-Immunotherapy trials since 2014 and the appearance of follow-up studies since 2015. During the first half of 2018, 41% of new CAR-Immunotherapy trials registered worldwide were not registered in ClinicalTrials.gov. Comparing the entire years from 2017 to 2018, the total number of trials increased from 152 to 234, and the number of phase 2-3-4 trials went from 10 to 24.

CAR-T Trials by phase versus year

Public samples:
AttachmentSize
SAMPLE CAR-immunotherapy Trials12.19 KB